ICFI · XBRL financial data
ICF International financial statements, every fiscal year
The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal years (ICFI's year ends in late December)
| In millions of dollars | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Revenue from contracts with customers | 1,507 | 1,553 | 1,780 | 1,963 | 2,020 | 1,873 |
| Cost of goods and services sold | 972 | 980 | 1,134 | 1,265 | 1,282 | 1,177 |
| Selling, general and administrative | 412 | 431 | 487 | 505 | 518 | 492 |
| Total operating expenses | 445 | 463 | 537 | 566 | 572 | 551 |
| Operating income (loss) | 89 | 111 | 109 | 132 | 166 | 145 |
| Interest expense | 14 | 10 | 24 | 40 | 30 | 31 |
| Other income (expense) | (1) | (1) | (2) | 4 | 2 | (3) |
| Income tax expense (benefit) | 20 | 29 | 20 | 14 | 28 | 20 |
| Net income (loss) | 55 | 71 | 64 | 83 | 110 | 92 |
| Earnings per share, basic USD per share | 2.92 | 3.77 | 3.41 | 4.39 | 5.88 | 4.97 |
| Earnings per share, diluted USD per share | 2.87 | 3.72 | 3.38 | 4.35 | 5.82 | 4.95 |
| Weighted average shares, basic millions of shares | 19 | 19 | 19 | 19 | 19 | 18 |
| Weighted average shares, diluted millions of shares | 19 | 19 | 19 | 19 | 19 | 19 |
Balance sheet
CSVFiscal years (ICFI's year ends in late December)
| In millions of dollars | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 14 | 8 | 11 | 6 | 5 | 5 |
| Accounts receivable | 223 | 238 | 232 | 205 | 257 | 238 |
| Prepaid and other current assets | 25 | 42 | 41 | 28 | 21 | 18 |
| Total current assets | 476 | 449 | 467 | 447 | 492 | 514 |
| Property and equipment, net | 62 | 52 | 85 | 76 | 68 | 58 |
| Right-of-use asset | 127 | 177 | 149 | 133 | 116 | 106 |
| Goodwill | 910 | 1,047 | 1,213 | 1,219 | 1,249 | 1,252 |
| Total assets | 1,667 | 1,850 | 2,092 | 2,012 | 2,066 | 2,050 |
| Accounts payable | 91 | 106 | 136 | 135 | 160 | 124 |
| Accrued liabilities | 101 | 61 | 78 | 79 | 87 | 71 |
| Current portion of long-term debt | 10 | 10 | 23 | 26 | 0 | — |
| Total current liabilities | 427 | 377 | 416 | 418 | 449 | 404 |
| Long-term debt | 303 | 412 | 533 | 404 | 412 | 401 |
| Lease liability, non-current | 116 | 192 | 182 | 175 | 156 | 140 |
| Total liabilities | 920 | 1,046 | 1,239 | 1,094 | 1,084 | 1,022 |
| Retained earnings | 589 | 649 | 703 | 775 | 875 | 956 |
| Total stockholders' equity | 747 | 803 | 853 | 918 | 982 | 1,028 |
| Total liabilities and equity | 1,667 | 1,850 | 2,092 | 2,012 | 2,066 | 2,050 |
| Common shares outstanding (cover page) millions of shares | 19 | 19 | 19 | 19 | 18 | 18 |
Cash flows
CSVFiscal years (ICFI's year ends in late December)
| In millions of dollars | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Net income (loss) | 55 | 71 | 64 | 83 | 110 | 92 |
| Stock-based compensation | 18 | 13 | 13 | 15 | 17 | 18 |
| Depreciation and amortization | 34 | 32 | 50 | 61 | 53 | 58 |
| Net cash from operating activities | 173 | 110 | 162 | 152 | 172 | 142 |
| Net cash from investing activities | (271) | (194) | (259) | (4) | (75) | (22) |
| Dividends paid | 11 | 11 | 11 | 11 | 11 | 10 |
| Repayments of long-term debt | 870 | 773 | 1,446 | 1,372 | 1,248 | 1,360 |
| Net cash from financing activities | 170 | 23 | 90 | (153) | (87) | (84) |
| Net change in cash | 76 | (62) | (7) | (4) | 9 | 38 |
Compare with peers
SIC 8742 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 8742 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
| Company | Cash ($M) | Revenue, quarter ($M) | Operating cash flow, quarter ($M) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| ICF International | 4.6 | 474 | 100* | 17.9M | — | 10-QJun 30, 2026 |
| Evolent Health | 116 | 653 | (9.3)* | 113.1M | 12.4 quarters | 10-QJun 30, 2026 |
| Premier | 43 | 240 | 16 | 82.7M | — | 10-QSep 30, 2025 |
| Astrana Health | 401 | 973 | 33* | 55.7M | — | 10-QJun 30, 2026 |
| Huron Consulting Group | 26 | 491 | 57* | 15.8M | — | 10-QSep 30, 2026 |
| Exponent | 67 | 172 | 31* | 47.5M | — | 10-QJul 3, 2026 |
| Onterris | 13 | 187 | 6.2* | 35.1M | — | 10-QJun 30, 2026 |
| V2X | 265 | 1,271 | 67* | 31.4M | — | 10-QOct 2, 2026 |
| TSS | 68 | 35 | 7.6* | 28.2M | — | 10-Q/AJun 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.